Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

Enhances Labcorp's laboratory services network and expands access to its clinical services  BURLINGTON, N.C. and MIAMI , Sept. 16, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc.

How eating healthy food can reduce the risk of developing prostate cancer

September not only marks the official end of summer but also the beginning of Prostate Cancer Awareness Month. While it experienced a decline in the early and mid-2000s, prostate cancer has had a resurgence in recent years.

Why cell line screening is crucial for successul complement-dependent cytotoxicity (CDC) assay development

Highlighgt new approach to CDC Assays for mAb characterization and QC release testing 

N-Glycan Characterization with LC-MS

High level discussion of Glycosylation, Monitoring, Method Selection, and Analysis

Centralized Analytical Laboratory White Paper

Benefits of using Labcorp Biopharm CMC services to reduce risks, costs, complexities, and time of client drug development journey

Labcorp Biopharmaceutical CMC Stability Services

Download

Biopharmaceutical Characterization: Setting the Foundation of Success in Your Drug Development

Download